Follow us:
Bioprocessing Summit Europe Virtual
Online, 16th-17th March
Ypso-Facto will attend Bioprocessing Summit Europe Virtual . To discuss further, contact us or book a meeting with Frédéric Cheviron .
UP-COMING WEBINAR - Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted
Online, 10th March 2021
Ypso-Facto co-presents a webinar entitled Manufacturing in the Industry 4.0 era: how to balance innovation with performance while not being disrupted with Christos Varsakelis of Janssen and Mark Demesmaeker of Sartorius . Roger-Marc Nicoud will present his views on Using predictive digital...
BIOKET Digital Edition
Online, 1st-19th March 2021
Ypso-Facto will attend BIOKET Digital Edition . Join in to listen to Yohann Le Guennec's presentation on "Modeling and simulation of ion-exchange in bioprocesses". To discuss further, contact us or book a meeting with Frédéric Cheviron . Visit our knowledge center to view...
UP-COMING WEBINAR - Deuterium in the 21st century, use in medicinal chemistry and synthetic methods
Online, 2nd March 2021, 4 pm CET
In this webinar, Thomas Jennequin will present insights on the use of Deuterium in medicinal chemistry and the advantages of having some deuterated positions on APIs. For instance, Deuterium can modify drug metabolization, pharmacokinetics, or toxicity. Thomas will highlight some of the challenges...
Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation
The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...
NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima
EASY: a disruptive mAb purification process to reduce cost of goods
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...
UP-COMING WEBINAR - Manufacturing in the industry 4.0 era: how to balance innovation with performance while not being disrupted
10th March, with C. Varsakelis (Janssen), Mark Demesmaeker (Sartorius) and RM Nicoud (Ypso-Facto)
FREE webinar! Save your seat now by registering online, here .
NEW ARTICLE – Fareva and Ypso-Facto investigate the purification of an antibiotic by ion-exchange
Using Mechanistic Modeling for Understanding Antibiotics Purification with Ion Exchange Chromatography
This article is based on a real industrial purification process by Fareva and highlights the power of mechanistic modeling for process development: Our client needed to change a raw material to secure his supply chain. From a process point of view, it was supposed to be seamless. However, a...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
Download
© Ypso-Facto 2014 - Powered by Ealys | Legal Information